

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA methylation involved in gamete generation (GO:0043046) | 7.51806159 |
| 2 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 7.46788088 |
| 3 | lipopolysaccharide biosynthetic process (GO:0009103) | 7.43245761 |
| 4 | protein-chromophore linkage (GO:0018298) | 7.34965979 |
| 5 | regulation of meiosis I (GO:0060631) | 6.88499438 |
| 6 | regulation of protein glycosylation (GO:0060049) | 6.77566479 |
| 7 | lipopolysaccharide metabolic process (GO:0008653) | 6.41196081 |
| 8 | regulation of pigment cell differentiation (GO:0050932) | 6.30472383 |
| 9 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.30346829 |
| 10 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 6.24334791 |
| 11 | sulfate transmembrane transport (GO:1902358) | 6.16040293 |
| 12 | positive regulation of developmental pigmentation (GO:0048087) | 6.07762107 |
| 13 | gamma-aminobutyric acid transport (GO:0015812) | 5.66304224 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.63202417 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 5.62934986 |
| 16 | paraxial mesoderm development (GO:0048339) | 5.61509159 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.57529807 |
| 18 | vocalization behavior (GO:0071625) | 5.56063029 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.51835395 |
| 20 | SMAD protein complex assembly (GO:0007183) | 5.43993104 |
| 21 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.43286847 |
| 22 | sulfate transport (GO:0008272) | 5.28561149 |
| 23 | synaptic vesicle exocytosis (GO:0016079) | 5.25828613 |
| 24 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.20334905 |
| 25 | neuronal action potential propagation (GO:0019227) | 5.04630654 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.99716093 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.97331858 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 4.97331858 |
| 29 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.83426582 |
| 30 | glutamate secretion (GO:0014047) | 4.74316120 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.73042626 |
| 32 | neuromuscular process controlling posture (GO:0050884) | 4.72917177 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.69301755 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.69295375 |
| 35 | positive regulation of meiosis (GO:0045836) | 4.67396983 |
| 36 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.58063223 |
| 37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.56745059 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.43392606 |
| 39 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.42917121 |
| 40 | serotonin receptor signaling pathway (GO:0007210) | 4.37017206 |
| 41 | protein localization to synapse (GO:0035418) | 4.36286231 |
| 42 | heme transport (GO:0015886) | 4.35017866 |
| 43 | startle response (GO:0001964) | 4.32472099 |
| 44 | positive regulation of meiotic cell cycle (GO:0051446) | 4.32458721 |
| 45 | notochord development (GO:0030903) | 4.32185252 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 4.20421840 |
| 47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14300102 |
| 48 | synaptic vesicle maturation (GO:0016188) | 4.11732594 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 4.11195019 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.11195019 |
| 51 | proline transport (GO:0015824) | 4.07286919 |
| 52 | neurotransmitter transport (GO:0006836) | 4.03168883 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.02061972 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 4.01479415 |
| 55 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.00422251 |
| 56 | ribonucleoprotein complex disassembly (GO:0032988) | 4.00099416 |
| 57 | neuron recognition (GO:0008038) | 3.99173744 |
| 58 | response to pheromone (GO:0019236) | 3.99046115 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.90488633 |
| 60 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.90331539 |
| 61 | locomotory exploration behavior (GO:0035641) | 3.87252977 |
| 62 | neuron-neuron synaptic transmission (GO:0007270) | 3.82317998 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.81687801 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.80521558 |
| 65 | detection of calcium ion (GO:0005513) | 3.79959005 |
| 66 | response to epinephrine (GO:0071871) | 3.75722706 |
| 67 | transmission of nerve impulse (GO:0019226) | 3.75156481 |
| 68 | positive regulation of synapse assembly (GO:0051965) | 3.73648596 |
| 69 | succinate metabolic process (GO:0006105) | 3.68815693 |
| 70 | righting reflex (GO:0060013) | 3.68480965 |
| 71 | centriole replication (GO:0007099) | 3.66872798 |
| 72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.64111053 |
| 73 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.63883306 |
| 74 | exploration behavior (GO:0035640) | 3.63514597 |
| 75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.63061297 |
| 76 | membrane hyperpolarization (GO:0060081) | 3.59915802 |
| 77 | regulation of protein kinase A signaling (GO:0010738) | 3.59837362 |
| 78 | rhodopsin mediated signaling pathway (GO:0016056) | 3.58420171 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 3.58270513 |
| 80 | tachykinin receptor signaling pathway (GO:0007217) | 3.56534757 |
| 81 | heart valve formation (GO:0003188) | 3.52068790 |
| 82 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.51749108 |
| 83 | glycerol metabolic process (GO:0006071) | 3.48861844 |
| 84 | iron coordination entity transport (GO:1901678) | 3.48791552 |
| 85 | presynaptic membrane assembly (GO:0097105) | 3.48430141 |
| 86 | axonal fasciculation (GO:0007413) | 3.48286648 |
| 87 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48030155 |
| 88 | toxin metabolic process (GO:0009404) | 3.47129369 |
| 89 | meiotic chromosome segregation (GO:0045132) | 3.46054111 |
| 90 | response to histamine (GO:0034776) | 3.44269440 |
| 91 | vitamin transmembrane transport (GO:0035461) | 3.42450799 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41249316 |
| 93 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.41033378 |
| 94 | regulation of interleukin-5 production (GO:0032674) | 3.40391261 |
| 95 | sympathetic nervous system development (GO:0048485) | 3.39368152 |
| 96 | nodal signaling pathway (GO:0038092) | 3.38800807 |
| 97 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.36106347 |
| 98 | negative regulation of stem cell proliferation (GO:2000647) | 3.34719715 |
| 99 | postsynaptic membrane organization (GO:0001941) | 3.32451041 |
| 100 | positive regulation of amino acid transport (GO:0051957) | 3.31358406 |
| 101 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.30261702 |
| 102 | aromatic amino acid family catabolic process (GO:0009074) | 3.28608867 |
| 103 | somite rostral/caudal axis specification (GO:0032525) | 3.27534089 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.24963341 |
| 105 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24868062 |
| 106 | cAMP-mediated signaling (GO:0019933) | 3.24785714 |
| 107 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.24107878 |
| 108 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.21075906 |
| 109 | regulation of odontogenesis (GO:0042481) | 3.20714390 |
| 110 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.19817900 |
| 111 | response to mercury ion (GO:0046689) | 3.19668666 |
| 112 | presynaptic membrane organization (GO:0097090) | 3.19126095 |
| 113 | positive regulation of membrane potential (GO:0045838) | 3.18934511 |
| 114 | germinal center formation (GO:0002467) | 3.18595508 |
| 115 | positive regulation of action potential (GO:0045760) | 3.18383581 |
| 116 | regulation of glutamate secretion (GO:0014048) | 3.18182469 |
| 117 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.15154691 |
| 118 | regulation of vesicle fusion (GO:0031338) | 3.12317566 |
| 119 | organelle disassembly (GO:1903008) | 3.11215677 |
| 120 | regulation of developmental pigmentation (GO:0048070) | 3.10772058 |
| 121 | pantothenate metabolic process (GO:0015939) | 3.08880264 |
| 122 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.08062499 |
| 123 | flavonoid metabolic process (GO:0009812) | 3.07101184 |
| 124 | dendritic spine morphogenesis (GO:0060997) | 3.06563738 |
| 125 | social behavior (GO:0035176) | 3.04171124 |
| 126 | intraspecies interaction between organisms (GO:0051703) | 3.04171124 |
| 127 | sulfur compound transport (GO:0072348) | 3.04087003 |
| 128 | synapse assembly (GO:0007416) | 3.03700455 |
| 129 | alditol metabolic process (GO:0019400) | 3.01074893 |
| 130 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 2.99719439 |
| 131 | synaptic vesicle endocytosis (GO:0048488) | 2.98751566 |
| 132 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.98201108 |
| 133 | synaptic transmission (GO:0007268) | 2.97646544 |
| 134 | activation of protein kinase A activity (GO:0034199) | 2.97310538 |
| 135 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.97014116 |
| 136 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.97014116 |
| 137 | chaperone-mediated protein transport (GO:0072321) | 2.96711070 |
| 138 | adult walking behavior (GO:0007628) | 2.95598367 |
| 139 | long-term memory (GO:0007616) | 2.95106329 |
| 140 | regulation of synapse assembly (GO:0051963) | 2.94232159 |
| 141 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.93081130 |
| 142 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.93015255 |
| 143 | regulation of neurotransmitter secretion (GO:0046928) | 2.92591612 |
| 144 | striatum development (GO:0021756) | 2.89532046 |
| 145 | piRNA metabolic process (GO:0034587) | 2.89287658 |
| 146 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89096504 |
| 147 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.88480344 |
| 148 | DNA damage induced protein phosphorylation (GO:0006975) | 2.88165116 |
| 149 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.87464832 |
| 150 | neurotransmitter metabolic process (GO:0042133) | 2.84880490 |
| 151 | calcium ion-dependent exocytosis (GO:0017156) | 2.84736868 |
| 152 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84460442 |
| 153 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.83865869 |
| 154 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83615410 |
| 155 | serotonin metabolic process (GO:0042428) | 2.83091942 |
| 156 | regulation of respiratory system process (GO:0044065) | 2.82245092 |
| 157 | lysine catabolic process (GO:0006554) | 2.82195822 |
| 158 | lysine metabolic process (GO:0006553) | 2.82195822 |
| 159 | negative regulation of amino acid transport (GO:0051956) | 2.82040906 |
| 160 | establishment of synaptic vesicle localization (GO:0097480) | 2.81890541 |
| 161 | synaptic vesicle transport (GO:0048489) | 2.81890541 |
| 162 | neurotransmitter biosynthetic process (GO:0042136) | 2.80529075 |
| 163 | membrane depolarization (GO:0051899) | 2.80134634 |
| 164 | long-term synaptic potentiation (GO:0060291) | 2.80118440 |
| 165 | behavioral fear response (GO:0001662) | 2.79985054 |
| 166 | behavioral defense response (GO:0002209) | 2.79985054 |
| 167 | regulation of synapse structural plasticity (GO:0051823) | 2.79799398 |
| 168 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.78575844 |
| 169 | cellular response to gamma radiation (GO:0071480) | 2.76506163 |
| 170 | aromatic amino acid family metabolic process (GO:0009072) | 2.76028471 |
| 171 | organ induction (GO:0001759) | 2.71026242 |
| 172 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.67779075 |
| 173 | behavioral response to ethanol (GO:0048149) | 2.67441458 |
| 174 | biotin metabolic process (GO:0006768) | 2.66608663 |
| 175 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.65864602 |
| 176 | regulation of keratinocyte proliferation (GO:0010837) | 2.64810685 |
| 177 | opioid receptor signaling pathway (GO:0038003) | 2.63866997 |
| 178 | inflammatory response to antigenic stimulus (GO:0002437) | 2.63294160 |
| 179 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.61644694 |
| 180 | phasic smooth muscle contraction (GO:0014821) | 2.60788151 |
| 181 | cofactor transport (GO:0051181) | 2.59663064 |
| 182 | SMAD protein signal transduction (GO:0060395) | 2.58173488 |
| 183 | regulation of hair follicle development (GO:0051797) | 2.57912965 |
| 184 | primary amino compound metabolic process (GO:1901160) | 2.57856230 |
| 185 | sphingosine metabolic process (GO:0006670) | 14.1070778 |
| 186 | diol metabolic process (GO:0034311) | 12.8269770 |
| 187 | sphingoid metabolic process (GO:0046519) | 11.5473851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.42074120 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.79403523 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03593515 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.97628526 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85259559 |
| 6 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56952865 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.55082330 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49718473 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47973025 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47973025 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47356809 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46033895 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41578015 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.41323109 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37940906 |
| 16 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.35941243 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.31285865 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31204986 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.28431450 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24857118 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24807189 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.24217972 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.06090770 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03650857 |
| 25 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00339282 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99965780 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97527356 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97099208 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93686227 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91741986 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91683832 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90882288 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88366917 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85147515 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85065792 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81565543 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81123325 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76840340 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76387307 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74009035 |
| 41 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.73590054 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70423109 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68113937 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66354559 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66286835 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66221411 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.65612922 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.65612922 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.65547627 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65437808 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63262538 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.58431646 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56257094 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55523410 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52702276 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51467551 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51220182 |
| 58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50516122 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49570619 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47526066 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46648096 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44066905 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42608907 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40448665 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35426530 |
| 66 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.34068840 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33596651 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33245162 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31458913 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30998454 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29068325 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28600255 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28580638 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27407325 |
| 75 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.26104260 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.24938073 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23633854 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21643547 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20615335 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.18786341 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18694968 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17992771 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17316633 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16540542 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16453244 |
| 86 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15541078 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14699039 |
| 88 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.14589306 |
| 89 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12703364 |
| 90 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12005358 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10795910 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10787938 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09920507 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09867131 |
| 95 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.09437116 |
| 96 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08538365 |
| 97 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.08214810 |
| 98 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08084351 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.08079211 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07898113 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07573740 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07511577 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07041553 |
| 104 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06668114 |
| 105 | * AR_19668381_ChIP-Seq_PC3_Human | 1.06211044 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05975113 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04822285 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04192531 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04114121 |
| 110 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03690664 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03286373 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02321985 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02283367 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02283367 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00785963 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00512768 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00512768 |
| 118 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00450710 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99907559 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99716273 |
| 121 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99716273 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98793226 |
| 123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98393176 |
| 124 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98284242 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97935866 |
| 126 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97614884 |
| 127 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96967243 |
| 128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96799544 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96537286 |
| 130 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95661528 |
| 131 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.95044433 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93869620 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92590632 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92261925 |
| 135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91236434 |
| 136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90464569 |
| 137 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90399664 |
| 138 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88740575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 7.07375081 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.74645847 |
| 3 | MP0003880_abnormal_central_pattern | 4.49970823 |
| 4 | MP0003890_abnormal_embryonic-extraembry | 4.45642650 |
| 5 | MP0003045_fibrosis | 4.10802717 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.88253638 |
| 7 | MP0009046_muscle_twitch | 3.81291808 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.42680030 |
| 9 | MP0009745_abnormal_behavioral_response | 3.34129582 |
| 10 | MP0002064_seizures | 3.22556678 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.96175139 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.91015684 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.89484423 |
| 14 | MP0004270_analgesia | 2.81244606 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.78192143 |
| 16 | MP0002272_abnormal_nervous_system | 2.78008534 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.66115027 |
| 18 | MP0001486_abnormal_startle_reflex | 2.55476456 |
| 19 | MP0005670_abnormal_white_adipose | 2.54923890 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.51887410 |
| 21 | MP0002822_catalepsy | 2.49159587 |
| 22 | MP0004381_abnormal_hair_follicle | 2.48376762 |
| 23 | MP0003122_maternal_imprinting | 2.46414755 |
| 24 | MP0004147_increased_porphyrin_level | 2.41296289 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.40161764 |
| 26 | MP0001529_abnormal_vocalization | 2.32604673 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.19628175 |
| 28 | MP0002736_abnormal_nociception_after | 2.16603559 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.16094004 |
| 30 | MP0004142_abnormal_muscle_tone | 2.10673462 |
| 31 | MP0003787_abnormal_imprinting | 1.99493884 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.99488229 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.96411530 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.95542910 |
| 35 | MP0002184_abnormal_innervation | 1.93562209 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.89409587 |
| 37 | MP0004924_abnormal_behavior | 1.89409587 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.87272879 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.84092404 |
| 40 | MP0000749_muscle_degeneration | 1.83901711 |
| 41 | MP0001970_abnormal_pain_threshold | 1.82592455 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.77995034 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.74370957 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.73983159 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.73682198 |
| 46 | MP0000778_abnormal_nervous_system | 1.71687728 |
| 47 | MP0001984_abnormal_olfaction | 1.70894786 |
| 48 | MP0002168_other_aberrant_phenotype | 1.64675802 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.59888539 |
| 50 | MP0002938_white_spotting | 1.49485532 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.48337160 |
| 52 | MP0003646_muscle_fatigue | 1.45830508 |
| 53 | MP0003195_calcinosis | 1.45191739 |
| 54 | MP0000955_abnormal_spinal_cord | 1.43384998 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.42465709 |
| 56 | MP0008569_lethality_at_weaning | 1.42350003 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.40376150 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.38664404 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.34281556 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.32296969 |
| 61 | MP0003121_genomic_imprinting | 1.31675276 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.31121901 |
| 63 | MP0003329_amyloid_beta_deposits | 1.29847434 |
| 64 | MP0001905_abnormal_dopamine_level | 1.29149352 |
| 65 | MP0002160_abnormal_reproductive_system | 1.28353690 |
| 66 | MP0000751_myopathy | 1.26950922 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.26304410 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.25696243 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.23884521 |
| 70 | MP0003123_paternal_imprinting | 1.19980628 |
| 71 | MP0005365_abnormal_bile_salt | 1.14209011 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.12556613 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.12259066 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.10086625 |
| 75 | MP0002095_abnormal_skin_pigmentation | 1.07634593 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.07291357 |
| 77 | MP0001188_hyperpigmentation | 1.06342509 |
| 78 | MP0002152_abnormal_brain_morphology | 1.05151182 |
| 79 | MP0003879_abnormal_hair_cell | 1.04814451 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.03472674 |
| 81 | MP0004043_abnormal_pH_regulation | 1.02468536 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 1.01524336 |
| 83 | MP0004233_abnormal_muscle_weight | 0.94914938 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.94367810 |
| 85 | MP0000427_abnormal_hair_cycle | 0.93414818 |
| 86 | MP0002075_abnormal_coat/hair_pigmentati | 0.92802756 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.92349472 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.90995169 |
| 89 | MP0002229_neurodegeneration | 0.90839088 |
| 90 | MP0005395_other_phenotype | 0.90532438 |
| 91 | MP0002102_abnormal_ear_morphology | 0.89414158 |
| 92 | MP0004885_abnormal_endolymph | 0.89309562 |
| 93 | MP0004858_abnormal_nervous_system | 0.89242927 |
| 94 | MP0005330_cardiomyopathy | 0.88764222 |
| 95 | MP0001177_atelectasis | 0.87904143 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.87561573 |
| 97 | MP0004085_abnormal_heartbeat | 0.86536416 |
| 98 | MP0004742_abnormal_vestibular_system | 0.85211768 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.84648646 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.83978684 |
| 101 | MP0008872_abnormal_physiological_respon | 0.76191710 |
| 102 | MP0005535_abnormal_body_temperature | 0.75394168 |
| 103 | MP0003633_abnormal_nervous_system | 0.75205384 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.74573543 |
| 105 | MP0004484_altered_response_of | 0.74296284 |
| 106 | MP0002269_muscular_atrophy | 0.72487648 |
| 107 | MP0001943_abnormal_respiration | 0.71287393 |
| 108 | MP0003631_nervous_system_phenotype | 0.70976772 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.70581736 |
| 110 | MP0002163_abnormal_gland_morphology | 0.70038358 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.69901311 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 0.67092725 |
| 113 | MP0005187_abnormal_penis_morphology | 0.66753914 |
| 114 | MP0008874_decreased_physiological_sensi | 0.66737534 |
| 115 | MP0002090_abnormal_vision | 0.65294858 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.64631772 |
| 117 | MP0000026_abnormal_inner_ear | 0.64164840 |
| 118 | MP0004130_abnormal_muscle_cell | 0.63592347 |
| 119 | MP0005171_absent_coat_pigmentation | 0.62586077 |
| 120 | MP0001186_pigmentation_phenotype | 0.60526394 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.58267125 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.57580373 |
| 123 | MP0003634_abnormal_glial_cell | 0.57249972 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.57015450 |
| 125 | MP0000604_amyloidosis | 0.56102182 |
| 126 | MP0005389_reproductive_system_phenotype | 0.55417233 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.55413252 |
| 128 | MP0005379_endocrine/exocrine_gland_phen | 0.55367267 |
| 129 | MP0005499_abnormal_olfactory_system | 0.55145891 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.55145891 |
| 131 | MP0005253_abnormal_eye_physiology | 0.55091143 |
| 132 | MP0003632_abnormal_nervous_system | 0.52944803 |
| 133 | MP0008770_decreased_survivor_rate | 0.50315866 |
| 134 | MP0001324_abnormal_eye_pigmentation | 0.49433798 |
| 135 | MP0000534_abnormal_ureter_morphology | 0.48291166 |
| 136 | MP0003252_abnormal_bile_duct | 0.46441279 |
| 137 | MP0009764_decreased_sensitivity_to | 0.44020484 |
| 138 | MP0005377_hearing/vestibular/ear_phenot | 0.42222900 |
| 139 | MP0003878_abnormal_ear_physiology | 0.42222900 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.41739417 |
| 141 | MP0005410_abnormal_fertilization | 0.41346994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.87811473 |
| 2 | Amelogenesis imperfecta (HP:0000705) | 8.51118955 |
| 3 | Atonic seizures (HP:0010819) | 6.75967876 |
| 4 | Acanthocytosis (HP:0001927) | 6.29160526 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 6.28145118 |
| 6 | Parakeratosis (HP:0001036) | 5.93055702 |
| 7 | Febrile seizures (HP:0002373) | 5.87458344 |
| 8 | Focal seizures (HP:0007359) | 5.86424878 |
| 9 | Myokymia (HP:0002411) | 5.27162410 |
| 10 | Absence seizures (HP:0002121) | 4.97398478 |
| 11 | Colon cancer (HP:0003003) | 4.76984570 |
| 12 | Dialeptic seizures (HP:0011146) | 4.59588669 |
| 13 | Epileptic encephalopathy (HP:0200134) | 4.54851688 |
| 14 | Aplastic anemia (HP:0001915) | 4.52329335 |
| 15 | Rectal prolapse (HP:0002035) | 4.39683377 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 4.21233451 |
| 17 | Hematochezia (HP:0002573) | 4.18637835 |
| 18 | Proximal amyotrophy (HP:0007126) | 3.98301571 |
| 19 | Vertebral arch anomaly (HP:0008438) | 3.94247178 |
| 20 | Progressive inability to walk (HP:0002505) | 3.93327757 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 3.89340466 |
| 22 | Visual hallucinations (HP:0002367) | 3.85402470 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.80619019 |
| 24 | Hyperventilation (HP:0002883) | 3.79307230 |
| 25 | Pendular nystagmus (HP:0012043) | 3.76581973 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.74491348 |
| 27 | Pancreatic cysts (HP:0001737) | 3.68487512 |
| 28 | Difficulty walking (HP:0002355) | 3.38329296 |
| 29 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.36706994 |
| 30 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.34143255 |
| 31 | Ulnar claw (HP:0001178) | 3.24256434 |
| 32 | Erythroderma (HP:0001019) | 3.12696354 |
| 33 | Scapular winging (HP:0003691) | 3.09844669 |
| 34 | Conjunctival telangiectasia (HP:0000524) | 3.06142113 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 2.98515950 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.97675277 |
| 37 | Broad-based gait (HP:0002136) | 2.96608687 |
| 38 | Polyphagia (HP:0002591) | 2.95664686 |
| 39 | Dysdiadochokinesis (HP:0002075) | 2.89783826 |
| 40 | Overlapping toe (HP:0001845) | 2.89695342 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87915363 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 2.83136091 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.82941717 |
| 44 | Poikilocytosis (HP:0004447) | 2.81149062 |
| 45 | Potter facies (HP:0002009) | 2.78685889 |
| 46 | Facial shape deformation (HP:0011334) | 2.78685889 |
| 47 | Broad ribs (HP:0000885) | 2.76815204 |
| 48 | Status epilepticus (HP:0002133) | 2.65398241 |
| 49 | Hypoplastic iliac wings (HP:0002866) | 2.65362973 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.65228894 |
| 51 | Gait imbalance (HP:0002141) | 2.63951672 |
| 52 | Termporal pattern (HP:0011008) | 2.63391959 |
| 53 | Insidious onset (HP:0003587) | 2.63391959 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.60766263 |
| 55 | Truncal ataxia (HP:0002078) | 2.57772225 |
| 56 | Generalized myoclonic seizures (HP:0002123) | 2.57303639 |
| 57 | Limb dystonia (HP:0002451) | 2.55552151 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.54830114 |
| 59 | Esophageal varix (HP:0002040) | 2.54485176 |
| 60 | Drooling (HP:0002307) | 2.53223914 |
| 61 | Excessive salivation (HP:0003781) | 2.53223914 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.52826900 |
| 63 | Decreased circulating renin level (HP:0003351) | 2.51631995 |
| 64 | Poor eye contact (HP:0000817) | 2.51023986 |
| 65 | Impaired social interactions (HP:0000735) | 2.50797159 |
| 66 | Abnormal social behavior (HP:0012433) | 2.50797159 |
| 67 | Pheochromocytoma (HP:0002666) | 2.47461850 |
| 68 | Mutism (HP:0002300) | 2.47321515 |
| 69 | Hypokalemia (HP:0002900) | 2.46628210 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.43815868 |
| 71 | Diplopia (HP:0000651) | 2.43815868 |
| 72 | Anxiety (HP:0000739) | 2.43230828 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.41111504 |
| 74 | Inability to walk (HP:0002540) | 2.40094410 |
| 75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.38675387 |
| 76 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.36721210 |
| 77 | Cerebellar dysplasia (HP:0007033) | 2.36631687 |
| 78 | Peripheral hypomyelination (HP:0007182) | 2.35192306 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.34826221 |
| 80 | Hyperthyroidism (HP:0000836) | 2.34320564 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 2.34303390 |
| 82 | Dysmetria (HP:0001310) | 2.34289751 |
| 83 | Abnormality of the labia minora (HP:0012880) | 2.32183220 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.31946725 |
| 85 | Acute encephalopathy (HP:0006846) | 2.30344592 |
| 86 | Type II lissencephaly (HP:0007260) | 2.29223162 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.28978622 |
| 88 | Radial bowing (HP:0002986) | 2.28440885 |
| 89 | Action tremor (HP:0002345) | 2.27835466 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.27301520 |
| 91 | Portal hypertension (HP:0001409) | 2.26431639 |
| 92 | Ulnar bowing (HP:0003031) | 2.24821415 |
| 93 | Abnormal hair whorl (HP:0010721) | 2.24224527 |
| 94 | Enlarged kidneys (HP:0000105) | 2.22935348 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.21792800 |
| 96 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.20464423 |
| 97 | Mitochondrial inheritance (HP:0001427) | 2.20159393 |
| 98 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.19538817 |
| 99 | Retinitis pigmentosa (HP:0000510) | 2.19235676 |
| 100 | Postural instability (HP:0002172) | 2.18971847 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.18564148 |
| 102 | Hemiparesis (HP:0001269) | 2.18472196 |
| 103 | Medial flaring of the eyebrow (HP:0010747) | 2.16301837 |
| 104 | Depression (HP:0000716) | 2.14807694 |
| 105 | Genetic anticipation (HP:0003743) | 2.13185416 |
| 106 | Absent speech (HP:0001344) | 2.12692891 |
| 107 | Nephronophthisis (HP:0000090) | 2.12478553 |
| 108 | Truncus arteriosus (HP:0001660) | 2.11652141 |
| 109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.09267837 |
| 110 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.09267837 |
| 111 | Abnormality of potassium homeostasis (HP:0011042) | 2.08978893 |
| 112 | Poor suck (HP:0002033) | 2.07523755 |
| 113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05257886 |
| 114 | Bradykinesia (HP:0002067) | 2.05209199 |
| 115 | Cystic liver disease (HP:0006706) | 2.04295320 |
| 116 | Ventricular fibrillation (HP:0001663) | 2.04280681 |
| 117 | Abnormality of the hepatic vasculature (HP:0006707) | 2.03278356 |
| 118 | Visceral angiomatosis (HP:0100761) | 2.03140749 |
| 119 | Syncope (HP:0001279) | 2.03087251 |
| 120 | Failure to thrive in infancy (HP:0001531) | 2.00667567 |
| 121 | Amblyopia (HP:0000646) | 1.99900729 |
| 122 | Torticollis (HP:0000473) | 1.99060808 |
| 123 | Specific learning disability (HP:0001328) | 1.98840652 |
| 124 | Narrow nasal bridge (HP:0000446) | 1.98529354 |
| 125 | Abnormal ciliary motility (HP:0012262) | 1.97867137 |
| 126 | Genital tract atresia (HP:0001827) | 1.97786089 |
| 127 | Focal dystonia (HP:0004373) | 1.97006808 |
| 128 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96890146 |
| 129 | Abnormality of macular pigmentation (HP:0008002) | 1.96845779 |
| 130 | Abnormality of salivation (HP:0100755) | 1.96519915 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.95236535 |
| 132 | Synostosis of carpal bones (HP:0005048) | 1.93138357 |
| 133 | Abnormal albumin level (HP:0012116) | 1.93020490 |
| 134 | Hypoalbuminemia (HP:0003073) | 1.93020490 |
| 135 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.92878077 |
| 136 | 2-3 toe syndactyly (HP:0004691) | 1.92714109 |
| 137 | Increased corneal curvature (HP:0100692) | 1.91513547 |
| 138 | Keratoconus (HP:0000563) | 1.91513547 |
| 139 | Agitation (HP:0000713) | 1.91439540 |
| 140 | Tarsal synostosis (HP:0008368) | 1.90312606 |
| 141 | Spastic gait (HP:0002064) | 1.90110409 |
| 142 | Absent/shortened dynein arms (HP:0200106) | 1.90010044 |
| 143 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90010044 |
| 144 | Esotropia (HP:0000565) | 1.89509700 |
| 145 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.89181198 |
| 146 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.88597679 |
| 147 | Vaginal atresia (HP:0000148) | 1.88236129 |
| 148 | Hypoventilation (HP:0002791) | 1.87885632 |
| 149 | Congenital stationary night blindness (HP:0007642) | 1.87293983 |
| 150 | Increased CSF lactate (HP:0002490) | 1.87258890 |
| 151 | Hemangiomatosis (HP:0007461) | 1.87172661 |
| 152 | Abnormality of the vocal cords (HP:0008777) | 1.86322985 |
| 153 | Ankle clonus (HP:0011448) | 1.85828339 |
| 154 | Chronic hepatic failure (HP:0100626) | 1.81530716 |
| 155 | Tubulointerstitial fibrosis (HP:0005576) | 1.79110398 |
| 156 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.78975177 |
| 157 | Synostosis involving bones of the feet (HP:0009140) | 1.78975177 |
| 158 | Tubular atrophy (HP:0000092) | 1.78840823 |
| 159 | Neuronal loss in central nervous system (HP:0002529) | 1.78393696 |
| 160 | Urinary urgency (HP:0000012) | 1.78346740 |
| 161 | Adactyly (HP:0009776) | 1.78311119 |
| 162 | Spastic tetraplegia (HP:0002510) | 1.77400611 |
| 163 | Abnormal protein glycosylation (HP:0012346) | 1.77230831 |
| 164 | Abnormal glycosylation (HP:0012345) | 1.77230831 |
| 165 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77230831 |
| 166 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77230831 |
| 167 | Neoplasm of the small intestine (HP:0100833) | 1.76861152 |
| 168 | Humeroradial synostosis (HP:0003041) | 1.75519314 |
| 169 | Synostosis involving the elbow (HP:0003938) | 1.75519314 |
| 170 | Sporadic (HP:0003745) | 1.75445425 |
| 171 | Hemiplegia (HP:0002301) | 1.74751302 |
| 172 | Psychosis (HP:0000709) | 1.74658944 |
| 173 | Severe visual impairment (HP:0001141) | 1.74510904 |
| 174 | Postural tremor (HP:0002174) | 1.74459843 |
| 175 | Chorioretinal atrophy (HP:0000533) | 1.74254926 |
| 176 | Lipoatrophy (HP:0100578) | 1.74236645 |
| 177 | Congenital hepatic fibrosis (HP:0002612) | 1.74146433 |
| 178 | Pancreatic fibrosis (HP:0100732) | 1.73096346 |
| 179 | Albinism (HP:0001022) | 1.71037271 |
| 180 | Gangrene (HP:0100758) | 1.70929227 |
| 181 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69496384 |
| 182 | Thickened calvaria (HP:0002684) | 1.68511558 |
| 183 | Vitreoretinal degeneration (HP:0000655) | 1.66877215 |
| 184 | Opisthotonus (HP:0002179) | 1.66602919 |
| 185 | Macular degeneration (HP:0000608) | 1.65197364 |
| 186 | Neoplasm of the adrenal cortex (HP:0100641) | 1.64926646 |
| 187 | Palmoplantar keratoderma (HP:0000982) | 1.63767640 |
| 188 | Dehydration (HP:0001944) | 1.63680293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK38L | 7.17468432 |
| 2 | NTRK3 | 4.44388122 |
| 3 | MAP3K4 | 3.76168982 |
| 4 | MAP3K9 | 3.69054152 |
| 5 | MARK1 | 3.68348519 |
| 6 | MAP3K12 | 3.63216226 |
| 7 | MAP2K7 | 3.45530741 |
| 8 | NLK | 2.66995120 |
| 9 | ZAK | 2.65346199 |
| 10 | FRK | 2.64570123 |
| 11 | CASK | 2.63512538 |
| 12 | MAP2K4 | 2.52445929 |
| 13 | ACVR1B | 2.51662470 |
| 14 | MINK1 | 2.47583774 |
| 15 | MAP2K2 | 2.17536384 |
| 16 | NTRK2 | 2.16302170 |
| 17 | KSR2 | 2.10765624 |
| 18 | LATS1 | 10.1868568 |
| 19 | MELK | 1.98277440 |
| 20 | PNCK | 1.97976482 |
| 21 | STK3 | 1.96756741 |
| 22 | ARAF | 1.95353424 |
| 23 | ERBB4 | 1.86160436 |
| 24 | TNIK | 1.83227578 |
| 25 | EPHA4 | 1.83143022 |
| 26 | NTRK1 | 1.73798592 |
| 27 | KSR1 | 1.71615416 |
| 28 | LATS2 | 1.65838490 |
| 29 | MAP3K6 | 1.55441044 |
| 30 | PAK6 | 1.52893540 |
| 31 | FES | 1.45591175 |
| 32 | MAPK13 | 1.44658527 |
| 33 | ADRBK2 | 1.41765472 |
| 34 | BMPR2 | 1.29503552 |
| 35 | PLK2 | 1.29484757 |
| 36 | CDK5 | 1.22718093 |
| 37 | ERBB3 | 1.22569441 |
| 38 | SIK2 | 1.20155681 |
| 39 | TAF1 | 1.18964748 |
| 40 | MUSK | 1.13552963 |
| 41 | GRK5 | 1.13173112 |
| 42 | CAMK2A | 1.13099690 |
| 43 | RAF1 | 1.11113816 |
| 44 | BCR | 1.04920434 |
| 45 | NME1 | 1.04917208 |
| 46 | MAP3K13 | 1.02875514 |
| 47 | PRPF4B | 0.99267402 |
| 48 | TYRO3 | 0.99267186 |
| 49 | PRKAA2 | 0.98261462 |
| 50 | PRKCG | 0.98149871 |
| 51 | CDK8 | 0.97685923 |
| 52 | PRKD3 | 0.96906950 |
| 53 | CSNK1A1L | 0.95770394 |
| 54 | CCNB1 | 0.95110487 |
| 55 | GRK7 | 0.94821793 |
| 56 | PDPK1 | 0.93322132 |
| 57 | BRAF | 0.92179228 |
| 58 | STK38 | 0.90115617 |
| 59 | PRKCE | 0.88620611 |
| 60 | UHMK1 | 0.88154294 |
| 61 | NEK2 | 0.87518153 |
| 62 | DAPK1 | 0.85831794 |
| 63 | DYRK2 | 0.84125139 |
| 64 | DAPK2 | 0.79394794 |
| 65 | TGFBR1 | 0.79308176 |
| 66 | CSNK1G2 | 0.78860936 |
| 67 | STK11 | 0.78705452 |
| 68 | TNK2 | 0.76209697 |
| 69 | PAK3 | 0.75928058 |
| 70 | CAMKK1 | 0.74329600 |
| 71 | MOS | 0.72612331 |
| 72 | ADRBK1 | 0.72501087 |
| 73 | RET | 0.72305097 |
| 74 | PHKG1 | 0.72212597 |
| 75 | PHKG2 | 0.72212597 |
| 76 | PIK3CG | 0.70824294 |
| 77 | MAP3K1 | 0.68946430 |
| 78 | FER | 0.65969836 |
| 79 | AKT3 | 0.63991521 |
| 80 | DYRK1A | 0.63109906 |
| 81 | SGK494 | 0.61300301 |
| 82 | SGK223 | 0.61300301 |
| 83 | OXSR1 | 0.61085748 |
| 84 | CDK14 | 0.61031230 |
| 85 | CDK18 | 0.60769708 |
| 86 | PRKD1 | 0.60257275 |
| 87 | MAP3K2 | 0.57010653 |
| 88 | CAMK2B | 0.56446624 |
| 89 | EIF2AK3 | 0.56220509 |
| 90 | PRKCH | 0.55980452 |
| 91 | SIK3 | 0.55816676 |
| 92 | CDK15 | 0.55500302 |
| 93 | WNK3 | 0.53637951 |
| 94 | PRKCZ | 0.53109362 |
| 95 | SGK2 | 0.51414358 |
| 96 | BMPR1B | 0.50629113 |
| 97 | VRK1 | 0.50009841 |
| 98 | CAMK2G | 0.48799260 |
| 99 | SGK1 | 0.48075007 |
| 100 | PINK1 | 0.48060692 |
| 101 | CSNK1G3 | 0.47612382 |
| 102 | LIMK1 | 0.46138798 |
| 103 | MAP2K1 | 0.46027026 |
| 104 | ROCK2 | 0.45683454 |
| 105 | PDK3 | 0.44991321 |
| 106 | PDK4 | 0.44991321 |
| 107 | RIPK4 | 0.44246625 |
| 108 | WNK4 | 0.43905264 |
| 109 | FGR | 0.43585796 |
| 110 | RPS6KA3 | 0.42684612 |
| 111 | PRKACA | 0.42324667 |
| 112 | CDK11A | 0.42219085 |
| 113 | STK39 | 0.41387516 |
| 114 | CDK3 | 0.40721885 |
| 115 | PDGFRA | 0.40716242 |
| 116 | TAOK1 | 0.39112500 |
| 117 | CAMK2D | 0.38943339 |
| 118 | CAMK1 | 0.38570856 |
| 119 | CSNK1E | 0.38489451 |
| 120 | IRAK3 | 0.37548668 |
| 121 | CDK19 | 0.37128432 |
| 122 | TSSK6 | 0.36436738 |
| 123 | PRKG1 | 0.36119300 |
| 124 | TGFBR2 | 0.33705654 |
| 125 | NUAK1 | 0.30431317 |
| 126 | CSNK1D | 0.28440564 |
| 127 | MAP3K7 | 0.23193423 |
| 128 | TAOK3 | 0.22545097 |
| 129 | NEK9 | 0.18320376 |
| 130 | GRK1 | 0.17158271 |
| 131 | MAPKAPK5 | 0.16408155 |
| 132 | MAP4K2 | 0.15957663 |
| 133 | TTK | 0.14920788 |
| 134 | PRKCI | 0.14736865 |
| 135 | PLK1 | 0.14372666 |
| 136 | PIM1 | 0.14157964 |
| 137 | CAMKK2 | 0.07653977 |
| 138 | ABL1 | 0.07573653 |
| 139 | TRIM28 | 0.07328686 |
| 140 | MAPK3 | 0.07120113 |
| 141 | CSNK1G1 | 0.07018255 |
| 142 | PRKACB | 0.06429964 |
| 143 | AKT2 | 0.06223137 |
| 144 | CHEK2 | 0.06156597 |
| 145 | CSNK1A1 | 0.02976359 |
| 146 | EIF2AK2 | 0.02487001 |
| 147 | MAPK8 | 0.02140226 |
| 148 | PDK1 | 0.01709782 |
| 149 | MAPK1 | 0.01472248 |
| 150 | INSRR | 0.01418871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.23206782 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.62969630 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.23676640 |
| 4 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.12488481 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.97558239 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.92475473 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.90257569 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.48341417 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.45658609 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38300568 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28740742 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24271315 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.23411929 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12111783 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.00261638 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.98549015 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88735463 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88132203 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.81773585 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.75160145 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70601589 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.68411017 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.62150419 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60502725 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.58695061 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.56595542 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55780589 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55354880 |
| 29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.54427763 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53729010 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.44557042 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42253070 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38776687 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38575678 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36814152 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35983333 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34205680 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33692780 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32652679 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28312872 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28136385 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27655314 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27200319 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24342983 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.24245143 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23551838 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21036860 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16416428 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13591912 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13254590 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07358484 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06598684 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05679371 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05455272 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.04991679 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.04926606 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04791393 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99755361 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99164213 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97702001 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95926682 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95662484 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88832492 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85592187 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84734092 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81639357 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80714131 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80458595 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.79032959 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.78355229 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78237292 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76551988 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73605803 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71869729 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70443702 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69364632 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69098537 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68337600 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68315713 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68000238 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66484431 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66396718 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64774207 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64460770 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64214812 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61984470 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61590889 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58943299 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.57089419 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56232922 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55044637 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54310123 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54226641 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53879162 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52357430 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49118327 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48455795 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47496170 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47131373 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45743562 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42998417 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.42988980 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41419911 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40936965 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40347824 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.40238727 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39940044 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39079913 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.37516801 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37458424 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36473081 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36236919 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35398745 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.33779089 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32730258 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31991417 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31847817 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.30902040 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30374384 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30159679 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29706618 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29464743 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.29401164 |
| 124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28888957 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28267219 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27823957 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27595245 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27438137 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25968130 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24339030 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24197001 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24063270 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22798829 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22663308 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18730665 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18571614 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18123286 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.17789860 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.17685588 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.14550627 |
| 141 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.14371173 |

